| P50 | author | Eduard Vieta | Q20090640 |
| | Mauricio Tohen | Q88971056 |
| P2093 | author name string | Carlos A Zarate | |
| | Gustavo Vázquez | |
| | Jorge M Tamayo | |
| P2860 | cites work | Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials | Q22241689 |
| | Measuring inconsistency in meta-analyses | Q27860655 |
| | Quantifying heterogeneity in a meta-analysis | Q27860672 |
| | Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction | Q46516221 |
| | A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression | Q46580881 |
| | Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial | Q46596821 |
| | Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of risperidone monotherapy. | Q46639906 |
| | Risperidone in the treatment of acute mania: double-blind, placebo-controlled study | Q46681460 |
| | Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial | Q46681464 |
| | Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial | Q46683979 |
| | Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies | Q46801835 |
| | A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder | Q46868872 |
| | Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study | Q46886132 |
| | Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study | Q46889468 |
| | Comparison of treatment-emergent extrapyramidal symptoms in patients with bipolar mania or schizophrenia during olanzapine clinical trials. | Q46903473 |
| | Superiority of lithium over verapamil in mania: a randomized, controlled, single-blind trial | Q46972748 |
| | Olanzapine versus placebo in the treatment of adolescents with bipolar mania | Q46979845 |
| | Lithium in the treatment of depression | Q48393793 |
| | A double-blind comparison of the effect of the antipsychotics haloperidol and olanzapine on sleep in mania | Q48475579 |
| | Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial. | Q48481499 |
| | Correlates of antimanic response to valproate | Q48910659 |
| | A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. | Q50278208 |
| | Verapamil for the treatment of acute mania: a double-blind, placebo-controlled trial. | Q50877463 |
| | Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. | Q50924784 |
| | Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. | Q50929769 |
| | Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial. | Q51903227 |
| | Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study. | Q52058150 |
| | Psychotropic drug prescription patterns among patients with bipolar I disorder. | Q52066927 |
| | Bias in treatment assignment in controlled clinical trials. | Q52874177 |
| | A meta-analysis of the use of typical antipsychotic agents in bipolar disorder. | Q52932623 |
| | The Use of Lithium in Affective Disorders: I. Acute Endogenous Depression | Q53765837 |
| | Patterns of Psychotropic Drug Prescription for U.S. Patients With Diagnoses of Bipolar Disorders | Q54192185 |
| | Problems and Limitations in Conducting Systematic Reviews | Q56528247 |
| | Analysing Data and Undertaking Meta-Analyses | Q58642714 |
| | Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial | Q59210536 |
| | Superiority of Lithium Over Verapamil in Mania | Q60473475 |
| | Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group | Q61480116 |
| | Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol | Q66891830 |
| | Prediction of antidepressant responses to lithium | Q67323798 |
| | Verapamil versus lithium in acute mania | Q67719817 |
| | Carbamazepine compared with lithium in the treatment of mania | Q68027502 |
| | Double-blind comparison of the effects of clonazepam and lorazepam in acute mania | Q68377026 |
| | Antidepressant effects of carbamazepine | Q68858071 |
| | Carbamazepine versus lithium in mania: a double-blind study | Q68936059 |
| | Carbamazepine compared to haloperidol in acute mania | Q69753057 |
| | Controlled evaluation of lithium and chlorpromazine in the treatment of manic states: An interim report | Q69864633 |
| | Persistent tardive dyskinesia in bipolar patients | Q69878537 |
| | [Carbamazepine in manic syndromes. A controlled double-blind study] | Q69884450 |
| | A Double-Blind Comparison of Lithium and Chlorpromazine in the Treatment of Manic States | Q69897530 |
| | Correlates of antimanic response to carbamazepine | Q69902133 |
| | A Comparison of Lithium Carbonate and Chlorpromazine in Mania | Q69916677 |
| | A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania | Q70539313 |
| | Carbamazepine in manic-depressive illness: a new treatment | Q71229902 |
| | The induction of mania. A natural history study with controls | Q72523118 |
| | Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression | Q73317622 |
| | Phenytoin as an antimanic anticonvulsant: a controlled study | Q73501981 |
| | A double-blind study comparing idazoxan and bupropion in bipolar depressed patients | Q73508054 |
| | Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder | Q73926624 |
| | Evidence-based psychiatric practice: implications for education and continuing professional development. Canadian Psychiatric Association position paper | Q74367776 |
| | Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders | Q79535158 |
| | Double-blind, placebo-controlled trial of divalproex monotherapy in the treatment of symptomatic youth at high risk for developing bipolar disorder | Q80339453 |
| | A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania | Q82844588 |
| | Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 |
| | Moclobemide vs. imipramine in bipolar depression: a multicentre double-blind clinical trial | Q28208895 |
| | Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study | Q28248076 |
| | Lithium salts in the treatment of psychotic excitement | Q28262417 |
| | Effectiveness of adjunctive antidepressant treatment for bipolar depression | Q28295408 |
| | Rapid Cycling in Manic-Depressives Induced by Tricyclic Antidepressants | Q28326442 |
| | Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group | Q28375949 |
| | The number needed to treat: a clinically useful measure of treatment effect | Q29619672 |
| | Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy. | Q33268080 |
| | Treatment of bipolar disorder: a systematic review of available data and clinical perspectives | Q33364302 |
| | Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico | Q33553208 |
| | A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. | Q33844681 |
| | Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). | Q34000973 |
| | Bipolar depression: pharmacotherapy and related therapeutic strategies | Q34052825 |
| | Comparison of efficacy of lithium carbonate and chlorpromazine in mania. Report of collaborative study group on treatment of mania in Japan | Q34052877 |
| | Treatment of bipolar depression, a review of the literature and a suggestion for an algorithm | Q34090921 |
| | Lithium Response in Unipolar Versus Bipolar Depression | Q34212310 |
| | Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study | Q34221866 |
| | Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression | Q34275783 |
| | Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression. A placebo-controlled trial | Q34502718 |
| | A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents | Q34568810 |
| | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania | Q34606256 |
| | Valproate in the treatment of acute mania. A placebo-controlled study | Q34613045 |
| | Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group | Q34727272 |
| | Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials | Q34749757 |
| | Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen | Q34757926 |
| | Treatment and prevention of mania: a Scandinavian perspective | Q35650306 |
| | Aripiprazole: in acute mania associated with bipolar I disorder | Q35747870 |
| | The use of placebo in clinical trials on bipolar disorder: a new approach for an old debate | Q35997742 |
| | Extended-release carbamazepine capsules : in bipolar I disorder | Q36227921 |
| | Meta-analysis: principles and procedures | Q36247440 |
| | Size of treatment effects and their importance to clinical research and practice | Q36347965 |
| | Review: antipsychotic plus mood stabiliser co-therapy is more effective than mood stabiliser mono-therapy at reducing acute bipolar mania | Q36891592 |
| | Magnitude of effect of lithium in short-term efficacy studies of moderate to severe manic episode | Q37030962 |
| | The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders | Q37558582 |
| | Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. | Q38383710 |
| | Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study. | Q38385608 |
| | Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study | Q38393141 |
| | A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. | Q38402146 |
| | A double-blind comparative study of clinical efficacy of verapamil versus lithium in acute mania | Q39325575 |
| | Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: A double-blind controlled study | Q39709837 |
| | A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder | Q39961276 |
| | Therapeutic effects of carbamazepine in affective illness: a preliminary report | Q40908871 |
| | Double-blind comparative clinical trial of pimozide and chlorpromazine in mania. A test of the dopamine hypothesis | Q41619043 |
| | Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history | Q41777076 |
| | Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study. | Q42149500 |
| | Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials | Q42164457 |
| | Lithium treatment of depression | Q42235773 |
| | A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. | Q42556946 |
| | A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. | Q42625302 |
| | Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial | Q42625897 |
| | Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder | Q42627601 |
| | Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group | Q43507067 |
| | Efficacy of lithium as acute treatment of manic-depressive illness | Q43647019 |
| | Trends in the treatment of bipolar disorder by outpatient psychiatrists | Q44013090 |
| | Olanzapine versus divalproex in the treatment of acute mania | Q44013092 |
| | Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study | Q44159999 |
| | A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder | Q44275529 |
| | Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial | Q44385585 |
| | Treatment of imipramine-resistant recurrent depression, IV: A double- blind crossover study of tranylcypromine for anergic bipolar depression | Q44555889 |
| | A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 |
| | Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studies | Q44581952 |
| | The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression | Q44674218 |
| | A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania | Q44684784 |
| | Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients | Q44710965 |
| | A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. | Q44877765 |
| | Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial | Q44915194 |
| | A double-blind comparison of valproate and lithium in the treatment of acute mania | Q44975667 |
| | Tranylcypromine versus imipramine in anergic bipolar depression | Q45000348 |
| | Demographic and clinical characteristics of individuals in a bipolar disorder case registry | Q45027844 |
| | Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol | Q45168624 |
| | A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder | Q45237779 |
| | Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group | Q45338046 |
| | A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents | Q46072648 |
| | Olanzapine compared to lithium in mania: a double-blind randomized controlled trial | Q46146139 |
| | Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study | Q46178044 |
| | Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study | Q46202394 |
| | Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. | Q46377270 |
| | Divalproex in the treatment of bipolar depression: a placebo-controlled study | Q46394405 |
| | Using metaanalysis to evaluate evidence: practical tips and traps. | Q46438036 |
| | A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder | Q46503060 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| | meta-analysis | Q815382 |
| | systematic review | Q1504425 |
| | bipolar I disorder | Q4915474 |
| P304 | page(s) | 813-832 | |
| P577 | publication date | 2010-02-04 | |
| P1433 | published in | The International Journal of Neuropsychopharmacology | Q7742309 |
| P1476 | title | Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis | |
| P478 | volume | 13 | |